teprotide has been researched along with Chronic Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (87.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawahito, Y; Matsuyama, M; Nakatani, T; Sano, H; Tsuchida, K; Yoshimura, R | 1 |
| Atlas, SA; Case, DB; Laragh, JH; Sullivan, PA | 1 |
| Feriozzi, S; Manzi, M; Santarossa, C | 1 |
| Cody, RJ; Covit, AB; Laragh, JH; Schaer, GL | 1 |
| Lieberman, J | 1 |
| Armstrong, PW | 1 |
| Svendsen, UG | 1 |
| Dluhy, RG; Hollenberg, NK; Mersey, JH; Williams, GH | 1 |
8 other study(ies) available for teprotide and Chronic Disease
| Article | Year |
|---|---|
Expression of lipoxygenase in human bladder carcinoma and growth inhibition by its inhibitors.
Topics: Aged; Aged, 80 and over; Apoptosis; Arachidonate 12-Lipoxygenase; Arachidonate 5-Lipoxygenase; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cell Division; Chronic Disease; Cystitis; Female; Flavanones; Flavonoids; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Immunoenzyme Techniques; Indoles; Lipoxygenase Inhibitors; Male; Middle Aged; Neoplasm Staging; Reference Values; Reverse Transcriptase Polymerase Chain Reaction; Teprotide; Tumor Cells, Cultured; Urinary Bladder; Urinary Bladder Neoplasms | 2003 |
Acute and chronic treatment of severe and malignant hypertension with the oral angiotensin-converting enzyme inhibitor captopril.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Blood Pressure; Captopril; Child; Chronic Disease; Diastole; Female; Heart Rate; Humans; Hypertension; Kidney Function Tests; Long-Term Care; Male; Middle Aged; Oligopeptides; Proline; Renin; Teprotide | 1981 |
[Essential hypertension: current therapeutic approach].
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Blood Pressure; Chronic Disease; Diet, Reducing; Diet, Sodium-Restricted; Diuretics; Enzyme Inhibitors; Humans; Hypertension; Middle Aged; Oligopeptides; Sympatholytics; Teprotide; Vasodilator Agents | 1982 |
Evaluation of a long-acting converting enzyme inhibitor (enalapril) for the treatment of chronic congestive heart failure.
Topics: Administration, Oral; Aged; Chronic Disease; Dipeptides; Enalapril; Female; Heart Failure; Hemodynamics; Humans; Hypotension, Orthostatic; Long-Term Care; Male; Middle Aged; Oligopeptides; Saralasin; Teprotide; Time Factors | 1983 |
Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis.
Topics: Adult; Age Factors; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arginine; Blood Pressure; Carboxypeptidases; Chronic Disease; Edetic Acid; Female; Hippurates; Humans; Lung Diseases; Male; Middle Aged; Oligopeptides; Peptidyl-Dipeptidase A; Prednisone; Sarcoidosis; Sex Factors; Teprotide | 1975 |
Contributions of hemodynamic monitoring to the treatment of chronic congestive heart failure.
Topics: Chronic Disease; Dobutamine; Dopamine; Heart; Heart Failure; Hemodynamics; Humans; Hydralazine; Monitoring, Physiologic; Nitrates; Nitroprusside; Phentolamine; Prazosin; Teprotide; Vasodilator Agents | 1979 |
Effects of the nonapeptide SQ 20.881 on the blood pressure of conscious normotensive and chronic hypertensive mice.
Topics: Animals; Blood Pressure; Chronic Disease; Hypertension, Renal; Mice; Oligopeptides; Teprotide | 1977 |
Relationship between aldosterone and bradykinin.
Topics: Adrenal Insufficiency; Adult; Aldosterone; Angiotensin II; Bradykinin; Chronic Disease; Humans; Middle Aged; Potassium; Renin; Teprotide | 1977 |